Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
about
Exploring the ocean for new drug developments: Marine pharmacologyPolyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert PanelThe Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.The M-superfamily of conotoxins: a review.Ethyl acetate extract from marine sponge Hyattella cribriformis exhibit potent anticancer activity by promoting tubulin polymerization as evidenced mitotic arrest and induction of apoptosis.Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.Total synthesis of zyzzyanones A-DRole of meningeal mast cells in intrathecal morphine-evoked granuloma formation.Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.Marinopyrroles: Unique Drug Discoveries Based on Marine Natural Products.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.Conotoxins as Tools to Understand the Physiological Function of Voltage-Gated Calcium (CaV) Channels.Ziconitide.CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
P2860
Q26748686-D2474E31-D68C-4711-8C93-E9A30D466A0DQ30039702-C1B23B6E-EC33-414E-A300-4B67BB65D0B1Q30396983-3187EB02-EB8B-4CED-AC0B-AF182C907703Q31111228-77342E5D-10D1-4F10-A73F-EF4C5C44D2CEQ34999276-3C4CB66E-0C84-49E5-A30C-9C6D0630D8BAQ35228629-8FDF674E-6AC7-4B23-9E74-B680995DD1CBQ36517220-BA071688-352B-4B6B-AF93-1FBDAD16172AQ36640093-AEDCC558-06A8-48B9-8FE4-659D3F90A66BQ37074848-294F02CF-9480-44D1-81ED-C6B63C1AFC31Q37095322-5575E48C-975B-4262-BDD6-B1AFD673984AQ37210080-7EF157EF-CFE9-46E0-93B9-F65F76642DE5Q37261060-34373E30-9869-49B9-BC70-8337DC3FC172Q37360619-E4E513A2-2C3E-4D85-807B-50B5F76794F0Q37753534-9D156BB4-3B79-45DA-B936-0D5CD939A932Q38579139-A86FDB09-C464-4065-97C1-C95AF6746E3BQ38727831-007DFF8F-C933-41F5-9E6D-988AF1211237Q39168504-CD53497E-E6D5-4937-BB1D-7867BE0988DCQ40349390-E9388060-B691-4210-8EFC-360EE7EC4C9FQ43485451-3506EFC9-DD1B-4C98-BB2B-2B9C30A608B1Q46508576-250079F0-6E76-4F21-82CB-B0727EEB8DE9Q58582878-BBB38CFE-FC18-459E-87DD-605D1AE9E874
P2860
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@ast
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@en
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@nl
type
label
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@ast
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@en
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@nl
prefLabel
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@ast
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@en
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@nl
P2093
P2860
P1476
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
@en
P2093
Annelies W de Kater
George M Shopp
James C Beck
Michael J Skov
P2860
P304
P356
10.1080/10915810701582970
P577
2007-09-01T00:00:00Z